Literature DB >> 35522391

Diabetes leading to heart failure and heart failure leading to diabetes: epidemiological and clinical evidence.

Alberto Palazzuoli1, Massimo Iacoviello2.   

Abstract

Type 2 diabetes mellitus (T2DM) is a risk factor that plays a major role in the onset of heart failure (HF) both directly, by impairing cardiac function, and indirectly, through associated diseases such as hypertension, coronary disease, renal dysfunction, obesity, and other metabolic disorders. In a population of HF patients, the presence of T2DM ranged from 20 to 40%, according to the population studied, risk factor characteristics, geographic area, and age, and it is associated with a worse prognosis. Finally, patients with HF, when compared with those without HF, show an increased risk for the onset of T2DM due to several mechanisms that predispose the HF patient to insulin resistance. Despite the epidemiological data confirmed the relationship between T2DM and HF, the exact prevalence of HF in T2DM comes from interventional trials rather than from observational registries aimed to prospectively evaluate the risk of HF occurrence in T2DM population. This review is focused on the vicious cycle linking HF and T2DM, from epidemiological data to prognostic implications.
© 2022. The Author(s).

Entities:  

Keywords:  Epidemiology; Heart failure; Prognosis; Type 2 diabetes mellitus

Year:  2022        PMID: 35522391     DOI: 10.1007/s10741-022-10238-6

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.654


  81 in total

1.  Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association.

Authors:  Biykem Bozkurt; Andrew J S Coats; Hiroyuki Tsutsui; Ca Magdy Abdelhamid; Stamatis Adamopoulos; Nancy Albert; Stefan D Anker; John Atherton; Michael Böhm; Javed Butler; Mark H Drazner; G Michael Felker; Gerasimos Filippatos; Mona Fiuzat; Gregg C Fonarow; Juan-Esteban Gomez-Mesa; Paul Heidenreich; Teruhiko Imamura; Ewa A Jankowska; James Januzzi; Prateeti Khazanie; Koichiro Kinugawa; Carolyn S P Lam; Yuya Matsue; Marco Metra; Tomohito Ohtani; Massimo Francesco Piepoli; Piotr Ponikowski; Giuseppe M C Rosano; Yasushi Sakata; Petar Seferović; Randall C Starling; John R Teerlink; Orly Vardeny; Kazuhiro Yamamoto; Clyde Yancy; Jian Zhang; Shelley Zieroth
Journal:  Eur J Heart Fail       Date:  2021-03-03       Impact factor: 15.534

2.  Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.

Authors:  Eri T Kato; Michael G Silverman; Ofri Mosenzon; Thomas A Zelniker; Avivit Cahn; Remo H M Furtado; Julia Kuder; Sabina A Murphy; Deepak L Bhatt; Lawrence A Leiter; Darren K McGuire; John P H Wilding; Marc P Bonaca; Christian T Ruff; Akshay S Desai; Shinya Goto; Peter A Johansson; Ingrid Gause-Nilsson; Per Johanson; Anna Maria Langkilde; Itamar Raz; Marc S Sabatine; Stephen D Wiviott
Journal:  Circulation       Date:  2019-03-18       Impact factor: 29.690

3.  Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

Authors:  M J Garcia; P M McNamara; T Gordon; W B Kannel
Journal:  Diabetes       Date:  1974-02       Impact factor: 9.461

Review 4.  2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.

Authors:  Francesco Cosentino; Peter J Grant; Victor Aboyans; Clifford J Bailey; Antonio Ceriello; Victoria Delgado; Massimo Federici; Gerasimos Filippatos; Diederick E Grobbee; Tina Birgitte Hansen; Heikki V Huikuri; Isabelle Johansson; Peter Jüni; Maddalena Lettino; Nikolaus Marx; Linda G Mellbin; Carl J Östgren; Bianca Rocca; Marco Roffi; Naveed Sattar; Petar M Seferović; Miguel Sousa-Uva; Paul Valensi; David C Wheeler
Journal:  Eur Heart J       Date:  2020-01-07       Impact factor: 29.983

5.  Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored.

Authors:  John J V McMurray; Hertzel C Gerstein; Rury R Holman; Marc A Pfeffer
Journal:  Lancet Diabetes Endocrinol       Date:  2014-03-13       Impact factor: 32.069

6.  Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure.

Authors:  Steven P Marso; Florian M M Baeres; Stephen C Bain; Bryan Goldman; Mansoor Husain; Michael A Nauck; Neil R Poulter; Richard E Pratley; Anne Bloch Thomsen; John B Buse
Journal:  J Am Coll Cardiol       Date:  2020-03-17       Impact factor: 24.094

7.  Diabetes mellitus, fasting glucose, and risk of cause-specific death.

Authors:  Alexander Thompson; Emanuele Di Angelantonio; Pei Gao; Nadeem Sarwar; Sreenivasa Rao Kondapally Seshasai; Stephen Kaptoge; Peter H Whincup; Kenneth J Mukamal; Richard F Gillum; Ingar Holme; Inger Njølstad; Astrid Fletcher; Peter Nilsson; Sarah Lewington; Rory Collins; Vilmundur Gudnason; Simon G Thompson; Naveed Sattar; Elizabeth Selvin; Frank B Hu; John Danesh
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245

8.  Heart failure hospitalisation relative to major atherosclerotic events in type 2 diabetes with versus without chronic kidney disease: A meta-analysis of cardiovascular outcomes trials.

Authors:  Julian W Sacre; Dianna J Magliano; Jonathan E Shaw
Journal:  Diabetes Metab       Date:  2021-03-17       Impact factor: 6.041

9.  Cardiovascular disease, heart failure, chronic kidney disease and depression independently increase the risk of incident diabetes.

Authors:  G A Nichols; E J Moler
Journal:  Diabetologia       Date:  2010-11-24       Impact factor: 10.122

10.  Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial.

Authors:  David Fitchett; Silvio E Inzucchi; Christopher P Cannon; Darren K McGuire; Benjamin M Scirica; Odd Erik Johansen; Steven Sambevski; Stefan Kaspers; Egon Pfarr; Jyothis T George; Bernard Zinman
Journal:  Circulation       Date:  2019-03-12       Impact factor: 29.690

View more
  1 in total

Review 1.  Inflammatory Mechanisms of Diabetes and Its Vascular Complications.

Authors:  Lyudmila V Nedosugova; Yuliya V Markina; Leyla A Bochkareva; Irina A Kuzina; Nina A Petunina; Irina Y Yudina; Tatiana V Kirichenko
Journal:  Biomedicines       Date:  2022-05-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.